|
SECNIDAZOLE
 INN SECNIDAZOLE
|
cas 3366-95-8 |
CLASS ANTIPARASITIC A NITROIMIDAZOLE ANTIMICROBIAL TREATMENT OF BACTERIAL VAGINOSIS IN ADULT WOMEN 5-NITROIMIDAZOLES ENTER THE BACTERIAL CELL AS AN INACTIVE PRODRUG WHERE THE NITRO GROUP IS REDUCED BY BACTERIAL ENZYMES TO RADICAL ANIONS. IT IS BELIEVED THAT THESE RADICAL ANIONS INTERFERE WITH BACTERIAL DNA SYNTHESIS OF SUSCEPTIBLE ISOLATES |
|
ATC code
J01RA07 P01AB07 |
PK parameters Tmax 4 HOUR VD 42 LITER Cl 1.5 LITER / HOUR PPB 5 PERCENT t1/2 17 HOUR
|
Target TARGET DNA |
DrugCentral Unknown |
Download SDF file |
1H-Imidazole-1-ethanol, alpha,2-dimethyl-5-nitro- Formula: C7H11N3O3 Calculated chemical properties: MW 185.19 NB_atoms 13 XLogP 0.48 PSA 75.623 NB_HD 1 NB_HA 5 fsp3 0.57 Lipinski(0=no;1=yes) 1 |
FDA NDA 209363 ( label) INN (SECNIDAZOLE) SOLOSEC (EVOFEM INC) APPROVAL= AP YEAR= 2017 NEWMOLECULARENTITY |
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |